Pilot Biologix SPRL
Pilot Biologix reported total assets of 639,129 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jul 2026).
The score of Pilot Biologix shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +13 % Total assets -10 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pilot Biologix's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 20,315 € | ||||
| Equity | 398,715 € | ||||
| Cash | 18,020 € | ||||
| EBITDA | 84,767 € | ||||
| Total assets | 639,129 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jul 2026
- Year ended 31 Dec 2024filed on 23 Jul 2025
- Year ended 31 Dec 2023filed on 22 Jul 2024
- Year ended 31 Dec 2022filed on 07 Jul 2023
- Year ended 31 Dec 2021filed on 19 Jul 2022
Pilot Biologix's financial analysis
- Solvency62.4%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pilot Biologix
Pilot Biologix's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0847.681.218
- VAT number
- BE0847681218
- Peppol
- Registered · 0208:0847681218 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 18 Jul 2012
- Registered office
- 2275 Lille
- Latest accounts
- 2025 · filed on 16 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Pilot Biologix (SPRL) has been based in Lille since 2012, active in: activities of holding companies. For 2025, it reports a net profit of 20,315 € and equity of 398,715 €; its revenue is not published. Its solvency stands at 62.4%, above the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pilot Biologix
Companies in the same business, of comparable size and area, outside its group.
- Induo Activities of holding companies Oostkamp · balance sheet 716,795 €
- Solidtec Activities of holding companies Duffel · balance sheet 455,776 €
- Govers Activities of holding companies Lille · balance sheet 961,688 €
- Brand Architecture Management Activities of holding companies Asse · balance sheet 272,592 €
- Tim Vandekerckhove Activities of head offices Kortrijk · balance sheet 813,521 €
- Enhanced Healthcare Management Activities of holding companies Knokke-Heist · balance sheet 577,463 €
- EG Consilium Activities of holding companies Buggenhout · balance sheet 194,137 €
- BB Patrimoine Activities of holding companies Jurbise · balance sheet 385,683 €
Frequently asked questions about Pilot Biologix
What is the revenue of Pilot Biologix?
Pilot Biologix files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pilot Biologix?
In Belgium, the VAT number is the company number prefixed with BE: BE0847681218 for Pilot Biologix, if the company is VAT-registered. Its company number (CBE) is 0847.681.218.
Where is the registered office of Pilot Biologix?
According to the CBE register, the registered office of Pilot Biologix is in 2275 Lille.
What is the equity of Pilot Biologix?
At the close of the 2025 financial year, the equity of Pilot Biologix amounts to 398,715 €, a solvency of 62.4% of total assets.
Who manages Pilot Biologix?
The register lists 1 active mandates at Pilot Biologix. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pilot Biologix
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →